Updated:
CellCarta Inc.
CellCarta is a global contract research organization headquartered in Montreal, providing precision medicine testing services for drug development.
CellCarta Inc.
CellCarta operates as a contract research organization (CRO) offering specialized laboratory services for drug development. Its service line spans immunology, histopathology, proteomics, genomics, and digital pathology. The firm supports clients across the full drug development cycle, from translational research through clinical trial testing. The company's geographic footprint includes laboratories and offices in North America, Europe, Australia, and Asia. Specific locations include Montreal and Halifax in Canada; Naperville, Illinois and Lake Forest, California in the United States; Gosselies and Antwerp in Belgium; Baulkham Hills in Australia; and Jining, China. The firm lists precision medicine testing as a core capability. CellCarta serves pharmaceutical and biotechnology companies. It does not disclose ownership structure, AUM, or the identity of its principals. The firm's website positions it as a partner for clinical and translational research projects but provides no details on its founding date, team size, or financials. The firm's structural differentiator is its global multi-site laboratory network, which allows it to offer a broad suite of testing modalities under one organization. This contrasts with many CROs that focus on a single technology or region. Without disclosed principals or financial data, the firm appears privately held with an undisclosed governance structure.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Montreal
Corporate office
Montreal, Quebec, Canada
Additional offices
Halifax, Nova Scotia, Canada · Naperville, IL, United States · Lake Forest, CA, United States · Gosselies, Belgium · Antwerp, Belgium · Baulkham Hills, Australia · Jining, China
Sector focus
Frequently asked questions
What services does CellCarta offer?
CellCarta provides specialty laboratory services for drug development, including immunology, histopathology, proteomics, genomics, and digital pathology testing. These services support the entire drug development cycle from translational research to clinical trials (per CellCarta website).
Where are CellCarta's laboratory locations?
CellCarta operates laboratory and office facilities in Montreal and Halifax (Canada); Naperville, IL and Lake Forest, CA (United States); Gosselies and Antwerp (Belgium); Baulkham Hills (Australia); and Jining, China (per CellCarta website).
Who owns CellCarta?
CellCarta does not publicly disclose its ownership structure. The firm's website and public materials list no named principals, investors, or parent companies. It is privately held.
Does CellCarta disclose its financial data?
CellCarta does not disclose AUM, revenue, or deployment figures. The firm's website provides no financial information.
Is CellCarta a family office?
No. CellCarta describes itself as a global contract research organization (CRO) providing laboratory services. There is no public indication it operates as a family office or asset manager.
What types of clients does CellCarta serve?
CellCarta serves pharmaceutical and biotechnology companies conducting drug development programs. Its services are designed to support both translational research and clinical trials (per CellCarta website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: